Hayley Lewis - Net Worth and Insider Trading
Hayley Lewis Net Worth
The estimated net worth of Hayley Lewis is at least $0 dollars as of 2024-05-05. Hayley Lewis is the See Remarks of Zosano Pharma Corp and owns about 1,422 shares of Zosano Pharma Corp (ZSANQ) stock worth over $0. Details can be seen in Hayley Lewis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Hayley Lewis has not made any transactions after 2021-06-04 and currently still holds the listed stock(s).
Transaction Summary of Hayley Lewis
Hayley Lewis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hayley Lewis owns 2 companies in total, including Zosano Pharma Corp (ZSANQ) , and KalVista Pharmaceuticals Inc (KALV) .
Click here to see the complete history of Hayley Lewis’s form 4 insider trades.
Insider Ownership Summary of Hayley Lewis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZSANQ | Zosano Pharma Corp | 2021-06-04 | See Remarks |
| KALV | KalVista Pharmaceuticals Inc | 2015-08-03 | See Remarks |
Hayley Lewis Latest Holdings Summary
Hayley Lewis currently owns a total of 1 stock. Hayley Lewis owns 1,422 shares of Zosano Pharma Corp (ZSANQ) as of June 4, 2021, with a value of $0.
Latest Holdings of Hayley Lewis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZSANQ | Zosano Pharma Corp | 2021-06-04 | 1,422 | 0.00 | 0 |
Holding Weightings of Hayley Lewis
Hayley Lewis Form 4 Trading Tracker
According to the SEC Form 4 filings, Hayley Lewis has made a total of 1 transactions in Zosano Pharma Corp (ZSANQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Zosano Pharma Corp is the sale of 49 shares on June 4, 2021, which brought Hayley Lewis around $1,384.
Insider Trading History of Hayley Lewis
- 1
Hayley Lewis Trading Performance
GuruFocus tracks the stock performance after each of Hayley Lewis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hayley Lewis is -52.77%. GuruFocus also compares Hayley Lewis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hayley Lewis within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Hayley Lewis's insider trading performs compared to the benchmark.
Performance of Hayley Lewis
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -40 | | | | | |
| Relative Return to S&P 500(%) | -37.95 | | | | | |
Hayley Lewis Ownership Network
Hayley Lewis Owned Company Details
What does Zosano Pharma Corp do?
Who are the key executives at Zosano Pharma Corp?
Hayley Lewis is the See Remarks of Zosano Pharma Corp. Other key executives at Zosano Pharma Corp include Chief Financial Officer Christine Matthews , director & Chief Executive Officer Steven Lo , and VP & Clinical Dev & Med Affairs Donald J Kellerman .
Zosano Pharma Corp (ZSANQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Zosano Pharma Corp (ZSANQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zosano Pharma Corp (ZSANQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Zosano Pharma Corp (ZSANQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zosano Pharma Corp Insider Transactions
Hayley Lewis Mailing Address
Above is the net worth, insider trading, and ownership report for Hayley Lewis. You might contact Hayley Lewis via mailing address: C/o Carbylan Therapeutics, Inc., 3181 Porter Drive, Palo Alto Ca 94304.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
